Evidence map›Paper›PMID 34011686›Full record

ReviewmSphere2021

Epidemiology of Multidrug-Resistant Pseudomonas aeruginosa in the Middle East and North Africa Region.

Mahmood Al-Orphaly, Hamad Abdel Hadi, Faiha Kamaleldin Eltayeb, Hissa Al-Hail, Bincy Gladson Samuel, Ali A Sultan, Sini Skariah

Abstract readReview
In one paragraph

Review in mSphere, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Prevalence and Antimicrobial Resistance ofInfectious disease reports · 2026
    Article
  5. Article
  6. Multidrug-resistant Pseudomonas aeruginosa in ICU patients and hospital surfaces: β-lactamase burden, biofilm formation and clonal spread.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  7. Article
  8. Multicenter Genomic Analysis of Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Observational
  14. Observational
  15. Article
  16. IJID regions · 2026
    Article
  17. Review
  18. Article
  19. Article
  20. Whole-genome sequencing reveals molecular characterization of carbapenem-resistantFrontiers in cellular and infection microbiology · 2026
    Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mahmood Al-OrphalyDepartment of Medical Education, Weill Cornell Medicine - Qatar, Education City, Qatar Foundation, Doha, Qatar.
Hamad Abdel HadiDepartment of Infectious Diseases, Communicable Diseases Centre, Hamad Medical Corporation, Doha, Qatar.
Faiha Kamaleldin EltayebDepartment of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar.
Hissa Al-HailDepartment of Medical Education, Weill Cornell Medicine - Qatar, Education City, Qatar Foundation, Doha, Qatar.
Bincy Gladson SamuelDepartment of Microbiology and Immunology, Weill Cornell Medicine - Qatar, Education City, Qatar Foundation, Doha, Qatar.
Ali A SultanDepartment of Microbiology and Immunology, Weill Cornell Medicine - Qatar, Education City, Qatar Foundation, Doha, Qatar als2026@qatar-med.cornell.edu sis2013@qatar-med.cornell.edu.ORCID 0000-0002-0342-0313
Sini SkariahDepartment of Microbiology and Immunology, Weill Cornell Medicine - Qatar, Education City, Qatar Foundation, Doha, Qatar als2026@qatar-med.cornell.edu sis2013@qatar-med.cornell.edu.ORCID 0000-0002-9125-1889

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the last decades, there has been a dramatic global increase in multidrug-resistant (MDR) pathogens particularly among Gram-negative bacteria (GNB).

Indexed as

Drug Resistance, Multiple, BacterialGenome, BacterialAfrica, NorthernAnti-Bacterial AgentsAntimicrobial StewardshipColistinCross InfectionMicrobial Sensitivity TestsMiddle EastPrevalencePseudomonas aeruginosaPseudomonas InfectionsAnti-Bacterial AgentsColistinantibiotic resistanceintensive care unitsMDRMENAMiddle East and North Africa regionmultidrug resistancePseudomonas aeruginosaurinary tract infections

Identifiers

PMID34011686
PMCPMC8265635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.